Discontinued — last reported Q4 '24
McKesson Business Sale Proceeds decreased by 95.6% to $4.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 95.6%, from $90.00M to $4.00M.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $83.00M | $240.00M | $39.00M | $90.00M | $4.00M |
| QoQ Change | — | +189.2% | -83.8% | +130.8% | -95.6% |
| YoY Change | — | +189.2% | -83.8% | +130.8% | -95.6% |